Professional
Added to YB: 2024-10-31
Pitch date: 2024-09-30
NTRA [bullish]
Natera, Inc.
+61.61%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
Market Cap
$28.8B
Pitch Price
$126.77
Price Target
N/A
Dividend
N/A
EV/EBITDA
-111.11
P/E
-133.35
EV/Sales
12.10
Sector
Biotechnology
Category
growth
Show full summary:
Artisan Global Equity Fund Portfolio Holding: Natera, Inc.
NTRA: Genetic tester Natera's Signatera™ blood test shows improved survival in colorectal cancer. Likely to become standard of care, risking liability for non-use. Near-term catalysts in other areas. $15B market opportunity. Strong returns in healthcare sector.
Read full article (1 min)